共 66 条
[1]
Corcoran RB(2012)EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib Cancer Discov 2 227-235
[2]
Montero-Conde C(2013)Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF-mutant thyroid carcinomas Cancer Discov 3 520-533
[3]
Prahallad A(2012)Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR Nature 483 100-103
[4]
Poulikakos PI(2010)RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF Nature 464 427-430
[5]
Yao Z(2015)BRAF mutants evade ERK-dependent feedback by different mechanisms that determine their sensitivity to pharmacologic inhibition Cancer Cell 28 370-383
[6]
Lito P(2012)Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas Cancer Cell 22 668-682
[7]
Shalem O(2014)Genome-scale CRISPR-Cas9 knockout screening in human cells Science 343 84-87
[8]
Lin L(2015)The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies Nat Genet 47 250-256
[9]
Kapoor A(2014)Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer Cell 158 185-197
[10]
Shao DD(2014)KRAS and YAP1 converge to regulate EMT and tumor survival Cell 158 171-184